Exchanges
BSE, NSE
Industry
Healthcare Service Provider
Issue
Book building

Suraksha Diagnostic IPO

₹441.00

0.00% on listing

Listing-day close · NSE · 6 Dec 2024 · issue price ₹441

Suraksha Diagnostic’s ₹846 crore IPO was priced at ₹441 a share. It listed on the NSE on 6 Dec 2024 and closed its first day at ₹441.00, up 0.00% on the issue price.

Timeline

  1. Opens
  2. Closes
  3. Allotment
  4. Refunds
  5. Shares in demat
  6. Listing

Issue details

Issue size
₹846 Cr
Fresh issue
—
Offer for sale
₹846 Cr
Lot size
34 shares
Minimum investment
₹14,994
Face value
₹2
Registrar
Kfin Technologies

Subscription

Suraksha Diagnostic IPO subscription by investor category
CategoryShares offeredTimes subscribed
Total—1.17×

Overall, from the basis of allotment.

Financials and valuation

Market cap (post-issue)
₹2,297 Cr
P/E (post-issue)
74.9
EPS (post-issue)
₹5.89
Price to book
13.1
ROE
14.09%
ROCE
21.46%
Debt to equity
0.20
PAT margin
10.57%
Promoter holding
61.07% → 48.78%

Financials as of 31 Mar 2024, from the offer documents.

Listing

Listing date
6 Dec 2024
Issue price
₹441
Open
₹438.00
High
₹449.00
Low
₹414.95
Close
₹441.00

Listing day on the NSE. The close was 0.00% on the issue price.

SURAKSHA DIAGNOSTIC share price today

FAQs

When did the Suraksha Diagnostic IPO open and close?

It opened on 29 Nov 2024 and closed on 3 Dec 2024.

What was the Suraksha Diagnostic IPO price?

The price band was ₹420–441 a share. The final issue price was ₹441.

What is the lot size and minimum investment?

One lot is 34 shares, ₹14,994 at ₹441 a share. Retail investors apply in whole lots.

How much did Suraksha Diagnostic raise?

₹846 crore: ₹846 crore offered by existing shareholders.

How many times was the Suraksha Diagnostic IPO subscribed?

1.17 times overall.

How did Suraksha Diagnostic list?

It listed on the NSE on 6 Dec 2024 at ₹438.00 and closed the day at ₹441.00, up 0.00% on the ₹441 issue price.

Who is the registrar of the Suraksha Diagnostic IPO?

Kfin Technologies handles the allotment, refunds and credit of shares.

For information only. Not investment advice or a research report.

Full disclaimer

See how an IPO fits your plan

Armor checks every holding against your goals, risk and timeline.

Get the app